Demystifying Bio-Techne: Insights From 4 Analyst Reviews
Demystifying Bio-Techne: Insights From 4 Analyst Reviews
揭開生物科技的神祕面紗：來自4條分析師評論的見解
4 analysts have shared their evaluations of Bio-Techne (NASDAQ:TECH) during the recent three months, expressing a mix of bullish and bearish perspectives.
近三個月來，有4位分析師分享了他們對Bio-Techne（納斯達克股票代碼：TECH）的評估，他們表達了看漲和看跌的觀點。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他們最近的評級，簡要介紹了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $85.75, with a high estimate of $95.00 and a low estimate of $81.00. This current average reflects an increase of 8.54% from the previous average price target of $79.00.
分析師對12個月目標股價的評估提供了更多見解，顯示平均目標價爲85.75美元，最高估計爲95.00美元，低估值爲81.00美元。目前的平均價格比之前的平均目標價79.00美元增長了8.54％。
Decoding Analyst Ratings: A Detailed Look
解碼分析師評級：詳細介紹
A comprehensive examination of how financial experts perceive...
對金融專家如何看...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。